Literature DB >> 6331168

Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens.

S A Huber, P A Lodge.   

Abstract

Male Balb/c mice inoculated with a heart-adapted variant of Coxsackievirus, group B, type 3 (Nancy) (CVB3M), develop extensive myocarditis and cytolytic activity to primary cultures of uninfected and infected myocytes. To elucidate the mechanisms of myocyte injury in myocarditis, two distinct cytolytic T-lymphocyte (CTL) populations were isolated by immunoadsorption of lymph node cells to glutaraldehyde-fixed uninfected and infected myocyte monolayers. One population preferentially adsorbed to and lysed uninfected myocytes (autoreactive CTLs), while the other adsorbed to and lysed CVB3M-infected myocytes (virus-specific CTL). Neither CTL population adsorbed to monolayers of HeLa, L929, or umbilical cord endothelial cells, or to myocytes infected with a related but nonmyocarditic Coxsackievirus B-3 variant ( CVB3o ). While both autoreactive and virus-specific CTLs induced myocarditis in vivo, the lesions caused by autoreactive CTLs were more extensive and necrotizing than those of virus-specific cells. These results support the hypothesis that CVB3 -induced myocarditis results, in part, from autoimmunity to myocyte antigens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331168      PMCID: PMC1900366     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Myocarditis in experimental Coxsackie B-3 infection.

Authors:  E I GRODUMS; G DEMPSTER
Journal:  Can J Microbiol       Date:  1959-12       Impact factor: 2.419

Review 2.  Coxsackie virus myopericarditis. A microbiological and clinical review.

Authors:  S Z Hirschman; G S Hammer
Journal:  Am J Cardiol       Date:  1974-08       Impact factor: 2.778

Review 3.  Adult heart disease due to the Coxsackie virus B infection.

Authors:  G S Sainani; E Krompotic; S J Slodki
Journal:  Medicine (Baltimore)       Date:  1968-03       Impact factor: 1.889

4.  Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.

Authors:  C Y Wong; J J Woodruff; J F Woodruff
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

5.  Studies on the mechanism of mucin secretion by cells of the porcine tracheal epithelium.

Authors:  K B Adler; A R Brody; J E Craighead
Journal:  Proc Soc Exp Biol Med       Date:  1981-01

Review 6.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

7.  Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy.

Authors:  J W Mason; M E Billingham; D R Ricci
Journal:  Am J Cardiol       Date:  1980-05       Impact factor: 2.778

8.  Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice.

Authors:  C J Gauntt; M D Trousdale; D R LaBadie; R E Paque; T Nealon
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

9.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

10.  Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes.

Authors:  S A Huber; L P Job; J F Woodruff
Journal:  Am J Pathol       Date:  1980-03       Impact factor: 4.307

View more
  81 in total

Review 1.  Immunomodulating therapy in experimental myocarditis.

Authors:  A Matsumori; C Kawai
Journal:  Springer Semin Immunopathol       Date:  1989

Review 2.  Coxsackievirus infection as a trigger of cardiac autoimmunity.

Authors:  L J Wolfgram; N R Rose
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 3.  Molecular mimicry as a mechanism for virus-induced autoimmunity.

Authors:  R S Fujinami; M B Oldstone
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

4.  Effects of zileuton on the development of autoimmune myocarditis in an experimental rat model.

Authors:  Ender Odemis; Sadi Turkay; Cemile Koca; Halil Kiyici; Ahmet Karadag; Reyhan Bayrak; Emin Mete; Ferhat Catal; Ramazan Yigitoglu
Journal:  Curr Ther Res Clin Exp       Date:  2007-07

5.  Mucosal immunization with high-mobility group box 1 in chitosan enhances DNA vaccine-induced protection against coxsackievirus B3-induced myocarditis.

Authors:  Maowei Wang; Yan Yue; Chunsheng Dong; Xiaoyun Li; Wei Xu; Sidong Xiong
Journal:  Clin Vaccine Immunol       Date:  2013-09-11

6.  In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.

Authors:  E K Godeny; C J Gauntt
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

7.  Treatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies.

Authors:  S Sriram; D J Topham; S K Huang; M Rodriguez
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.

Authors:  A Henke; S Huber; A Stelzner; J L Whitton
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3.

Authors:  S A Huber; B Pfaeffle
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen.

Authors:  N Van Houten; P E Bouchard; A Moraska; S A Huber
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.